287 related articles for article (PubMed ID: 31086463)
1. Immune response pattern varies with the natural history of chronic hepatitis B.
Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
3. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.
Li Y; Wang JJ; Gao S; Liu Q; Bai J; Zhao XQ; Hao YH; Ding HH; Zhu F; Yang DL; Zhao XP
PLoS One; 2014; 9(2):e86927. PubMed ID: 24520324
[TBL] [Abstract][Full Text] [Related]
4. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
5. Association among cytokine profiles of innate and adaptive immune responses and clinical-virological features in untreated patients with chronic hepatitis B.
Gu Y; Lian Y; Zheng Q; Huang Z; Gu L; Bi Y; Li J; Huang Y; Wu Y; Chen L; Huang Y
BMC Infect Dis; 2020 Jul; 20(1):509. PubMed ID: 32664850
[TBL] [Abstract][Full Text] [Related]
6. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
7. Recovery of circulating CD56
Liu N; Liu B; Zhang L; Li H; Chen Z; Luo A; Chen M; Peng M; Yin W; Ren H; Hu P
Int Immunopharmacol; 2018 Sep; 62():59-66. PubMed ID: 29990695
[TBL] [Abstract][Full Text] [Related]
8. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
[TBL] [Abstract][Full Text] [Related]
9. NK cell phenotypic and functional shifts coincide with specific clinical phases in the natural history of chronic HBV infection.
de Groen RA; Hou J; van Oord GW; Groothuismink ZMA; van der Heide M; de Knegt RJ; Boonstra A
Antiviral Res; 2017 Apr; 140():18-24. PubMed ID: 28093337
[TBL] [Abstract][Full Text] [Related]
10. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
Vanwolleghem T; Hou J; van Oord G; Andeweg AC; Osterhaus AD; Pas SD; Janssen HL; Boonstra A
Hepatology; 2015 Jul; 62(1):87-100. PubMed ID: 25808668
[TBL] [Abstract][Full Text] [Related]
12. TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Boni C; Vecchi A; Rossi M; Laccabue D; Giuberti T; Alfieri A; Lampertico P; Grossi G; Facchetti F; Brunetto MR; Coco B; Cavallone D; Mangia A; Santoro R; Piazzolla V; Lau A; Gaggar A; Subramanian GM; Ferrari C
Gastroenterology; 2018 May; 154(6):1764-1777.e7. PubMed ID: 29378197
[TBL] [Abstract][Full Text] [Related]
13. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
[TBL] [Abstract][Full Text] [Related]
15. Functional restoration of CD56
Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
[TBL] [Abstract][Full Text] [Related]
16. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
[TBL] [Abstract][Full Text] [Related]
17. CD56
Shi A; Zhang X; Xiao F; Zhu L; Yan W; Han M; Luo X; Chen T; Ning Q
J Viral Hepat; 2018 Nov; 25(11):1352-1362. PubMed ID: 29888839
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
Park JJ; Wong DK; Wahed AS; Lee WM; Feld JJ; Terrault N; Khalili M; Sterling RK; Kowdley KV; Bzowej N; Lau DT; Kim WR; Smith C; Carithers RL; Torrey KW; Keith JW; Levine DL; Traum D; Ho S; Valiga ME; Johnson GS; Doo E; Lok AS; Chang KM;
Gastroenterology; 2016 Mar; 150(3):684-695.e5. PubMed ID: 26684441
[TBL] [Abstract][Full Text] [Related]
19. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
20. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM
J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
